miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6
- 2 August 2016
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 83, 792-797
- https://doi.org/10.1016/j.biopha.2016.07.037
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Targeting CDK4 and CDK6: From Discovery to TherapyCancer Discovery, 2016
- MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expressionBiomedicine & Pharmacotherapy, 2016
- MiR-221 promotes stemness of breast cancer cells by targeting DNMT3bOncotarget, 2015
- Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer TreatmentClinical Cancer Research, 2015
- MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signalingOncotarget, 2015
- Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancerOncotarget, 2015
- The history and future of targeting cyclin-dependent kinases in cancer therapyNature Reviews Drug Discovery, 2015
- MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancerTumor Biology, 2015
- Computational andin vitroInvestigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics StrategyBioinformatics and Biology Insights, 2015
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004